MÜSİLAJ TEMASI SONRASI STREPTOCOCCUS PYOGENES İLE GELİŞEN YUMUŞAK DOKU ENFEKSİYONU

Yıl 2024, , 79 - 83, 30.08.2024

Yeşim Çağlar , Muhammet Öksüzoğlu

https://doi.org/10.54962/ankemderg.1459648

Öz

Küresel ısınma etkisiyle, deniz bitkilerinin salgıladıkları organik maddelerden müsilaj oluşmaktadır. Müsilajın bazı patojen bakterileri konsantre etme özelliği bulunmaktadır ve bol miktarda bakteri ve virüs barındırmaktadır. Streptococcus pyogenes ve Streptococcus agalactiae için hayvanlar taşıyıcı olmasa bile ters-zoonoz olarak etkeni taşıyabilmektedir. Grup A Streptokoklar (GAS); yumuşak doku enfeksiyonlarına neden olmaktadır. İnsanlarda doğrudan nekrotizan fasiite sebep olan etkenlerin yanı sıra, evcil hayvanlar ve bazı su canlılarından insanlara bulaşan ve nekrotize fasiite sebep olan zoonoz karakterli etkenler de mevcuttur. Bu raporda; müsilaj teması sonrası S. pyogenes enfeksiyonu gelişen ve seyrinde hipoestezi gözlenen bir olgu sunulmuştur.

Anahtar Kelimeler

: Müsilaj, Streptococcus pyogenes, yumuşak doku enfeksiyonu, hipoestezi

Etik Beyan

Hastadan izin alınmıştır.

Destekleyen Kurum

YOK

Proje Numarası

PROJE DESTEĞİ YOKTUR

Teşekkür

-

SOFT TISSUE INFECTION WITH STREPTOCOCCUS PYOGENES AFTER MUCILAGE CONTACT

Öz

Mucilage is produced from organic substances secreted by marine plants due to global warming. Mucilage has the ability to concentrate some pathogenic bacteria and harbours abundant bacteria and viruses. For Streptococcus pyogenes and Streptococcus agalactiae, even if animals are not hosts, they can carry the agent as reverse zoonosis. Group A Streptococci (GAS) cause soft tissue infections. In addition to the agents that directly cause necrotizing fasciitis in humans, there are also zoonotic agents that are transmitted from domestic animals and some marine organisms to humans and cause necrotizing fasciitis. In this report, a case of S. pyogenes infection after mucilage contact and observed hypoesthesia during its course was presented.

Anahtar Kelimeler

Streptococcus pyogenes, soft tissue infection, hypoesthesia, musilage

Proje Numarası

PROJE DESTEĞİ YOKTUR

Kaynakça

• 1. Avire NJ, Whiley H, Ross K. A review of Streptococcus pyogenes: public health risk factors. Prevent Control Pathog. 2021;10(2):248.
• 2. Barker FG, Leppard BJ, Seal DV. Streptococcal necrotising fasciitis: comparison between histological and clinical features. J Clin Pathol. 1987;40(3):335-41.
• 3. Frazee BW, Fee C, Lynn J, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med. 2008;34(2):139-46.
• 4. Goh T, Goh LG, Ang CH et al. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101(1):e119–25.
• 5. Gül K. Diyabetes Mellitus Sınıflama, Tanı ve Tarama Testlerine Genel Bakış. KSU Tıp Fak Der. 2015;10(2):12-6.
• 6. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993;269(3):384-49.
• 7. Hollm-Delgado MG, Allard R, Pilon PA. Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001. Emerg Infect Dis. 2005;11(1):77-82.
• 8. Islam Z, Jacobs BC, van Belkum A, et al. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology . 2010;74(7):581-87.
• 9. Kavzoğlu T, Çölkesen İ, Sefercik UG, Öztürk MY. Marmara Denizi’ndeki müsilaj oluşumlarının çok zamanlı optik ve termal uydu görüntülerinden makine öğrenme algoritması ile tespiti ve analizi. Harita Derg. 2021;87(166):1-9.
• 10. Lau SK, Woo PC, Tse H, Leung KW, Wong SS, Yuen KY. Invasive Streptococcus iniaeinfection soutside North America. J Clin Microbiol. 2003;41(3):1004-49.
• 11. Lee AS, Dyer JR. Severe Streptococcus zooepidemicus infection in a gardener. Med J Aust 2004;180(7):366.
• 12. Luca-Harari B, Darenberg J, Neal S, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2009;47(4):1155-65.
• 13. Madsen MB, Skrede S, Perner A, Arnell P, Nekludov M, Bruun T, et al. Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med. 2019;45(9):1241-51.
• 14. Marcet VJ, Carter JD, Vasey FB. Soft tissue disease. Rheum Dis Clin North Am. 2003;29(1):77-88.
• 15. Nuwayhid ZB, Aronoff DM, Mulla ZD. Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol. 2007;17(11):878-81.
• 16. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35(3):268-76.
• 17. O'Grady KA, Kelpie L, Andrews RM, et al. The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Med J Aust. 2007;186(11):565-59.
• 18. O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007;45(7):853-62.
• 19. Orieux, A., Prevel, R., Dumery, M. et al. Invasive group A streptococcal infections requiring admission to ICU: a nationwide, multicenter, retrospective study (ISTRE study). Crit Care. 2024;28(1):4.
• 20. Öncül O, Aktaş Z. Potential clinical hazards of pathogenic microorganisms ın mucilage. “Albay M (eds): Mucilage problem in the sea of Marmara, 1. Baskı” kitabında s.21-91, Istanbul University Publication No:5316, İstanbul (2023).
• 21. Öztürk AS, Köse SI. Gizli Tehdit: Et Yiyen Zoonoz Bakteriler. KSÜ Tıp Fak Derg. 2019;14(1):42-8.
• 22. Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72(9):1213-27.
• 23. Stevens DL. Invasive group A streptococcal disease. Infect Agents Dis. 1996;5(3):157-66.
• 24. Topkaya AE, Balıkçı A, Aydın F. Türkiye’de invazif streptokok enfeksiyonlarının epidemiyolojisi, klinik ve mikrobiyolojik özellikleri, 2010-2011. Mikrobiyol Bul. 2014;48(1):1-13.
• 25. Uncini A. Guillain-Barré syndrome: what have we learnt during one century? A personal historical perspective. Rev Neurol. 2016;172(10):632-44.